3 ASX 200 stocks I'd buy and hold for the next 10 years

Looking for stocks to hold onto for the long term. These three could be just the ticket according to analysts.

| More on:
A happy young couple lie on a wooden deck using a skateboard for a pillow.

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

There's something powerful about backing a great business and simply holding on. Not for six months. Not until the next earnings update. But for a full decade — riding the waves, ignoring the noise, and letting compounding do its thing.

The ASX may not have as many high-flying tech names as Wall Street, but it certainly has its fair share of world-class businesses. The kind that are growing globally, delivering strong earnings, and quietly building shareholder wealth year after year.

Here are three ASX 200 stocks that analysts rate as buys that I'd feel confident holding all the way through to 2035.

Life360 Inc. (ASX: 360)

Life360 is a location technology company known for its eponymous family safety app. It is gaining serious traction, with its user base reaching around 80 million.

The business model is sticky, the monetisation levers are only just beginning to turn, and management has its eyes on expanding into other complementary areas, which could bring valuation upside.

With a large addressable market, expanding product suite, and strong user engagement, Life360 could look like a very different business in a decade. And at current levels, long-term investors may be getting in before the real growth kicks in.

Goldman Sachs has a buy rating and $27.00 price target on its shares.

ResMed Inc. (ASX: RMD)

Another ASX 200 stock that could be a top buy and hold option is ResMed. It is one of the ASX's global healthcare success stories. This medical device company is a leader in sleep disorder treatment, offering devices, masks, and cloud-connected software that support patients across the globe.

Despite recent share price pressure linked to weight-loss drugs (GLP-1s), the company's fundamentals remain incredibly strong. ResMed continues to grow its earnings, expand margins, and generate serious cash flow. In fact, GLP-1s have helped to raise awareness of sleep apnoea, which appears to be expanding its addressable market at a quicker than expected rate.

What makes it a compelling 10-year hold is the sheer scale of the problem it solves. Sleep apnoea is underdiagnosed and growing globally, and ResMed has the brand power, distribution, and tech stack to remain the leader in the space.

Goldman Sachs is also very bullish on ResMed and has a conviction buy rating and $49.00 price target on its shares.

WiseTech Global Ltd (ASX: WTC)

Finally, WiseTech could be a great ASX 200 stock to buy and hold. It has built one of the most dominant software platforms in global logistics. Its CargoWise system is used by some of the largest freight companies in the world to manage customs, compliance, and end-to-end supply chains.

With recurring revenue, huge scalability, and strong customer retention, WiseTech is everything you want in a long-term growth investment.

So, with its shares down sharply from their highs, now could be an opportune time to invest. Macquarie certainly thinks so. It recently put an outperform rating and $152.70 price target on its shares.

Motley Fool contributor James Mickleboro has positions in Life360, ResMed, and WiseTech Global. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has positions in and has recommended Goldman Sachs Group, Life360, Macquarie Group, ResMed, and WiseTech Global. The Motley Fool Australia has positions in and has recommended Macquarie Group, ResMed, and WiseTech Global. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Growth Shares

Three happy office workers cheer as they read about good financial news on a laptop.
Growth Shares

5 ASX growth shares to buy and hold

Analysts think these shares could be top picks for investors looking for growth options.

Read more »

Two players on a field pump their fists in the air, indicating two of the best
Growth Shares

The ultimate buy and hold ASX 200 shares for long-term investors

These buy-rated shares could be great options for investors with a long time horizon.

Read more »

A bearded man holds both arms up diagonally and points with his index fingers to the sky with a thrilled look on his face over these rising Tassal share price
Growth Shares

3 unstoppable ASX shares to buy and hold for the next decade

These shares are going places over the remainder of the decade and beyond.

Read more »

Four piles of coins, each getting higher, with trees on them.
Growth Shares

2 high-growth ASX shares to buy today: brokers

These stocks have a strong growth outlook.

Read more »

Two university students in the library, one in a wheelchair, log in for the first time with the help of a lecturer.
Growth Shares

2 top-quality ASX shares to buy for beginner investors

These stocks could be a great place to start investing.

Read more »

A man in full American NFL playing kit crouches over with his arms across his chest in a defensive stance against a dark background.
Growth Shares

Here's why these two ASX 300 shares are great ones to own

These businesses are two of the fastest-growing stocks in the ASX 300 and are liked by fund manager WAM.

Read more »

A smiling businessman in the city looks at his phone and punches the air in celebration of good news.
Growth Shares

3 ASX growth shares you'll wish you bought in June

Analysts think these shares could be destined for big things in the future.

Read more »

Father and daughter with hands on a small plant.
ETFs

Focused on growth? Here are 3 ASX ETFs to consider

Growth investors must ignore the current market noise about tariffs and focus on the long-term horizon.

Read more »